News

South Africa's Kganyago asserts Africa's G20 agenda despite tariffs and Bessent absence
South African Reserve Bank Governor Lesetja Kganyago said on Wednesday that an "African agenda" including climate change and ...
BioSpace2d
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
AllAfrica on MSN2d
South Africa Gets R520 Million to Buy the Twice-a-Year Anti-HIV Jab - But There's a Snag
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir. Research shows the shot could help end Aids in ...
G20 a chance for South Africa to redefine global leadership
The world is facing more and more conflicts. The Russia-Ukraine war is the biggest in Europe since World War II. In the ...
South Africa Aims to Forge G-20 Accord Despite Ongoing US Enmity
South Africa expressed confidence that it can get finance ministers and central bank governors from the Group of 20 nations ...
ArcelorMittal South Africa says little progress made to avert plant closure
Talks with the South African government have so far yielded little progress to avert the closure of loss-making long steel ...
US aid cuts halt HIV vaccine research in South Africa, with global impact
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...